Daiwa Securities Group
VERA icon

Daiwa Securities Group’s Vera Therapeutics VERA Stock Holding History

Daiwa Securities Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-183
Closed -$9K – 1441
2025
Q4 		$9K Buy
183
+1
+0.5% +$36 ﹤0.01% 1196
2025
Q3 		$5K Hold
182
– – ﹤0.01% 1211
2025
Q2 		$4K Hold
182
– – ﹤0.01% 1180
2025
Q1 		$4K Hold
182
– – ﹤0.01% 1155
2024
Q4 		$8K Hold
182
– – ﹤0.01% 1137
2024
Q3 		$8K Hold
182
– – ﹤0.01% 1147
2024
Q2 		$7K Hold
182
– – ﹤0.01% 1182
2024
Q1 		$8K Hold
182
– – ﹤0.01% 1183
2023
Q4 		$3K Buy
+182
New +$2.31K ﹤0.01% 1256

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Daiwa Securities Group's VERA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 183 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in VERA in Q4 2023 and held it in 9 quarters. The position peaked at $9K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 183 Vera Therapeutics shares in Q1 2026, an estimated $9K.
  • Daiwa Securities Group first reported a position in Vera Therapeutics in Q4 2023 and held it in 9 quarters.
  • Daiwa Securities Group's Vera Therapeutics position peaked at $9K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.